Sleep disorders in Parkinson's disease

Sleep disorders in Parkinson's disease

Nocturnal sleep disorders are common and clinically significant neuropsychic manifestations of Parkinson's disease (PD).Objective: to specify the clinical features of sleep disorders in patients with PD and to evaluate the impact of dopaminergic therapy on the basic characteristics of sleep and...

Full description

Bibliographic Details
Main Author:	M. R. Nodel
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2011-03-01
Series:	Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:	parkinson's disease insomnia pramipexole
Online Access:	https://nnp.ima-press.net/nnp/article/view/74

Similar Items

Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole
by: M. R. Nodel
Published: (2011-12-01)

Apathy in Parkinson's disease patients
by: M. R. Nodel
Published: (2014-05-01)

Current possibilities of therapy for sleep disorders in Parkinson’s disease
by: Marina Romanovna Nodel
Published: (2013-11-01)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
by: Hametner EM, et al.
Published: (2012-03-01)

Sleep disorders in Parkinson’s disease: approaches to treatment and prevention
by: M. R. Nodel, et al.
Published: (2017-12-01)

Analysis of pramipexole dose–response relationships in Parkinson's disease
by: Wang Y, et al.
Published: (2016-12-01)

Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®)
by: M. R. Nodel
Published: (2011-09-01)

Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease
by: S N Illarioshkin
Published: (2012-06-01)

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)

Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy
by: Marina Romanovna Nodel
Published: (2012-03-01)

COGNITIVE AND AFFECTIVE DISORDERS AT EARLY STAGES OF PARKINSON’S DISEASE
by: R. R. Bogdanov, et al.
Published: (2016-02-01)

Sustained-release pramipexole in the treatment of Parkinson’s disease
by: Natalia Vladimirovna Fedorova
Published: (2012-03-01)

Comparison of nocturnal symptoms in advanced Parkinson’s disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations
by: Xiang W, et al.
Published: (2018-07-01)

Comorbid functional shoulder pain and zolpidem dependence treated with pramipexole
by: Dhiraj Kandre, et al.
Published: (2015-01-01)

Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review
by: Mutsumi Iijima, et al.
Published: (2015-06-01)

Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease
by: M. R. Nodel, et al.
Published: (2018-12-01)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
by: Angela Deutschländer, et al.
Published: (2016-01-01)

A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole
by: Ratih S. I. Putri, et al.
Published: (2016-11-01)

SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE
by: N. V. Fedorova, et al.
Published: (2014-07-01)

SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE
by: N. V. Fedorova, et al.
Published: (2014-07-01)

THE РERSONALITY PROFILE OF PATIENTS WITH EARLY MANIFESTATIONS OF PARKINSON'S DISEASE
by: R. R. Bogdanov, et al.
Published: (2016-07-01)

The Preparation of theragnostic immunoliposomes/immunoniosomes and therapy of Parkinson's disease
by: Silindir Gunay, Mine
Published: (2016)

Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Pramipexole in a Patient with Parkinson’s Disease
by: Yoonjae Choi, et al.
Published: (2011-05-01)

Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Pramipexole in a Patient with Parkinson’s Disease
by: Yoonjae Choi, et al.
Published: (2010-10-01)

Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients
by: Müge Kuzu, et al.
Published: (2016-09-01)

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders
by: Mónica M. Kurtis, et al.
Published: (2018-05-01)

Sleep Disorders in Parkinson’s Disease
by: Prachaya Srivanitchapoom, et al.
Published: (2017-04-01)

A Pilot Study to Determine the Consistency of Simultaneous Sleep Actigraphy Measurements Comparing All Four Limbs of Patients with Parkinson Disease
by: Vineet Prasad, et al.
Published: (2017-12-01)

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats
by: C. Marin, et al.
Published: (2014-04-01)

The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients
by: Faddoul L, et al.
Published: (2018-12-01)

Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment
by: Thomas A. Shepherd, et al.
Published: (2017-07-01)

(<i>S</i>)-Pramipexole and Its Enantiomer, Dexpramipexole: A New Chemoenzymatic Synthesis and Crystallographic Investigation of Key Enantiomeric Intermediates
by: Samuele Ciceri, et al.
Published: (2020-08-01)

NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE
by: M. R. Nodel', et al.
Published: (2009-06-01)

Depression in Parkinson's disease
by: M. R. Nodel'
Published: (2010-12-01)

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease
by: Chun-Feng Liu, et al.
Published: (2018-01-01)

HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE
by: M. R. Nodel
Published: (2016-12-01)

On the heterogeneity of depression in Parkinson’s disease
by: M. R. Nodel, et al.
Published: (2020-10-01)

Mécanismes physiopathologiques des comportements impulsifs associés à la maladie de Parkinson : approches expérimentales chez le rat
by: Magnard, Robin
Published: (2019)

Altérations du système de récompense dans la maladie de Parkinson : relation entre comportement et signatures moléculaires. : Neuropsychopharmacologie.
by: Loiodice, Simon
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k03n4ci8v7l9nljnkt8ebfeavd